Childhood Medulloblastoma
📧 Sign up to get email alerts when something new happens for Childhood Medulloblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT [Phase 2]
Phase 2 trial comparing Ga-DOTATOC PET sensitivity to Octreoscan SPECT+CT in medulloblastoma and related neuroendocrine tumors; results post…
-
CLINICAL_TRIALS trial_result · 2020-10-29Clinical Trial Update: Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer [Phase 3]
Phase 3 trial comparing fixed versus flexible dosing of filgrastim to speed bone marrow recovery after chemotherapy in children; the study i…
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors [Phase 1]
Phase 1 trial investigating palbociclib isethionate in pediatric CNS tumors; status terminated with posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors [Phase 1]
A Phase 1 trial evaluating veliparib (ABT-888) in combination with temozolomide for pediatric patients with recurrent or refractory CNS tumo…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma [Phase 1]
This phase 1 trial assessed safety and preliminary activity of the HDAC inhibitor vorinostat combined with bortezomib in pediatric patients …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas [Phase 1]
Phase 1 study of oxaliplatin with irinotecan in pediatric patients with refractory solid tumors or lymphomas has been completed.